- Home
- FINW vs NVRO Comparison
FINW vs NVRO Comparison
Compare FINW & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- NVRO
- Stock Information
- Founded
- FINW 1999
- NVRO 2006
- Country
- FINW United States
- NVRO United States
- Employees
- FINW N/A
- NVRO N/A
- Industry
- FINW Commercial Banks
- NVRO Medical/Dental Instruments
- Sector
- FINW Finance
- NVRO Health Care
- Exchange
- FINW Nasdaq
- NVRO Nasdaq
- Market Cap
- FINW 259.1M
- NVRO 221.2M
- IPO Year
- FINW 2021
- NVRO 2014
- Fundamental
- Price
- FINW $17.44
- NVRO $5.84
- Analyst Decision
- FINW Buy
- NVRO Hold
- Analyst Count
- FINW 4
- NVRO 12
- Target Price
- FINW $20.75
- NVRO $7.24
- AVG Volume (30 Days)
- FINW 16.9K
- NVRO 1.3M
- Earning Date
- FINW 04-28-2025
- NVRO 03-04-2025
- Dividend Yield
- FINW N/A
- NVRO N/A
- EPS Growth
- FINW N/A
- NVRO N/A
- EPS
- FINW 0.93
- NVRO N/A
- Revenue
- FINW $69,824,000.00
- NVRO $408,518,000.00
- Revenue This Year
- FINW $43.52
- NVRO $1.55
- Revenue Next Year
- FINW $21.91
- NVRO $4.36
- P/E Ratio
- FINW $18.75
- NVRO N/A
- Revenue Growth
- FINW 9.10
- NVRO N/A
- 52 Week Low
- FINW $9.56
- NVRO $3.17
- 52 Week High
- FINW $20.94
- NVRO $14.43
- Technical
- Relative Strength Index (RSI)
- FINW 41.71
- NVRO 70.30
- Support Level
- FINW $17.10
- NVRO $5.77
- Resistance Level
- FINW $17.54
- NVRO $5.81
- Average True Range (ATR)
- FINW 0.44
- NVRO 0.03
- MACD
- FINW -0.02
- NVRO -0.02
- Stochastic Oscillator
- FINW 52.57
- NVRO 95.00
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank also has established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.